These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10830342)

  • 21. The comparative clinical and economic benefits of drugs should be established and discussed as part of any formulary decision process.
    Richardson MS; Bowers BW; Petrie JL
    Am J Manag Care; 2002 Aug; 8(8):693-4; author reply 694-5. PubMed ID: 12212757
    [No Abstract]   [Full Text] [Related]  

  • 22. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].
    MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831
    [No Abstract]   [Full Text] [Related]  

  • 23. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stabilization treatments of migraine].
    Regli F; Nater B; Dworak N
    Praxis (Bern 1994); 1995 Sep; 84(38):1032-5. PubMed ID: 7481301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Triptans in migraine: from clinical view].
    Manaka S
    No To Shinkei; 2004 Sep; 56(9):739-45. PubMed ID: 15552862
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of sumatriptan in a managed care population.
    Legg RF; Sclar DA; Nemec NL; Tarnai J; Mackowiak JI
    Am J Manag Care; 1997 Jan; 3(1):117-22. PubMed ID: 10169243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migraine: diagnosis, management, and new treatment options.
    Gallagher RM; Cutrer FM
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S58-73. PubMed ID: 11859906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit.
    Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans].
    Slof J; Badia X; Lainez-Andres JM; Galvan J; Heras J
    Neurologia; 2005; 20(6):290-8. PubMed ID: 16007512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials.
    Belsey JD
    Curr Med Res Opin; 2004 May; 20(5):659-69. PubMed ID: 15140331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
    Burstein R; Collins B; Jakubowski M
    Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
    Kato K
    No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861
    [No Abstract]   [Full Text] [Related]  

  • 36. [New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain].
    MMW Fortschr Med; 2002 Jan; 144(3-4):52-3. PubMed ID: 11862794
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality of life in migraine.
    Mannix LK; Solomon GD
    Clin Neurosci; 1998; 5(1):38-42. PubMed ID: 9523057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New anti-migraine drugs: present and beyond the millennium.
    Limmroth V; Diener HC
    Int J Clin Pract; 1998; 52(8):566-70. PubMed ID: 10622056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migraine management. New approaches focus on serotonin receptors.
    DeRaps PK
    Adv Nurse Pract; 1999 May; 7(5):51-5. PubMed ID: 10578735
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacoeconomic evidence and considerations for triptan treatment of migraine.
    Caro JJ; Getsios D
    Expert Opin Pharmacother; 2002 Mar; 3(3):237-48. PubMed ID: 11866674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.